Dark

Check out our Dark Pool Levels

APHB
Ampliphi Biosciences Corp
stock NYSEAMERICAN

Inactive

May 9, 2019

4.45USD-20.326%(-1.14)334,186

Pre-market

Dec 31, 1969 7:00:00 PM EST

0.00USD0.000%(0.00)0

After-hours

Dec 31, 1969 7:00:00 PM EST

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 5, 2022

08:04AM EST Armata Pharma Updates On Pseudomonas Respiratory Programs RTTNews

08:03AM EST Armata Pharmaceuticals Provides Update on Pseudomonas Respiratory Programs PR Newswire

Nov 18, 2021

08:10AM EST Armata Announces FDA Clearance Of IND To Initiate Phase 1b/2a Trial Of AP-SA02 In Staphylococcus Aureus Bacteremia RTTNews

08:02AM EST Armata Pharmaceuticals Provides Regulatory and Clinical Update Reflecting PR Newswire

Nov 4, 2021

08:00AM EDT Armata Pharmaceuticals to Present at the 2021 World Antimicrobial Resistance PR Newswire

Oct 28, 2021

06:42PM EDT Cystic Fibrosis Foundation Makes Equity Investment in Armata Pharmaceuticals PR Newswire

Jul 7, 2021

07:31AM EDT Armata Pharmaceuticals to Present at the Ladenburg Thalmann 2021 Healthcare PR Newswire

Jan 27, 2021

07:21AM EST Armata Enters Agreement To Sell Common Stock And Warrant Securities To Innoviva Strategic Opportunities LLC RTTNews

07:01AM EST Armata Pharmaceuticals Announces $20 Million Investment to Support Advancement PR Newswire

Dec 9, 2020

07:31AM EST Armata Pharma Adds Robin Kramer To Board RTTNews

07:30AM EST Armata Pharmaceuticals Announces the Addition of Robin C. Kramer to its Board PR Newswire

Sep 11, 2020

07:31AM EDT Armata Pharmaceuticals Announces Participation in Upcoming Investor Conferences PR Newswire

Share